Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
europe blog main
europe top stories
5
×
life sciences
national blog main
national top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
cancer
covid-19
eli lilly
gilead sciences
novartis
sanofi
startups
What
bio
roundup
acquisitions
ceo
daniel
debut
drug
gilead
moves
o’day
sciences
week
abbvie’s
ahead
alkermes
announced
antipsychotic
benefits
biggest
biofourmis
black
bucks
build
buy
cancer
caveats
celebrate
chance
collabs
commonly
companies
company’s
continue
corner
covid
day
days
deal
designed
diamond
Language
unset
5
×
Current search:
abbvie
×
unset
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More